Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

Telix Pharmaceuticals has bought US-based radioisotope manufacturer RLS Radiopharmacies to expand its manufacturing footprint ...

After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, taking up the top science spot at Sanofi.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) shares are trading lower by 4.11% to $15.62 during Tuesday’s session after the ...

"If patients with low or no PD-L1 expression are not expected to benefit based on the available data, then administering anti ...

Laura Foran's late husband, Gerry, had a desk plaque that said, "I'm kind of a big deal." The 47-year-old Allentown woman is ...

Tracey Marantal has joined Worldwide Clinical Trials, a global full-service contract research organization (CRO), as President of the Oncology Business Unit. With over two decades of clinical ...

1 Day BMY 1.84% DJIA 0.72% S&P 500 0.54% Health Care/Life Sciences -0.83% ...

Whim Syndrome Management Market value is expected to USD 17.91 million by 2033, growing at a CAGR of 6% during the forecast ...

An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...

Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...